This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Xiamen University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Inventor Xinrui Wu
Introduction
Xinrui Wu is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals through his innovative research and development. His work focuses on compounds that have the potential to impact the treatment of diseases associated with PIKfyve kinase.
Latest Patents
Xinrui Wu holds a patent for "Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof." This patent describes a type of substituted penta-fused hexa-heterocyclic compound that selectively inhibits PIKfyve kinase. The patent also includes a method for the preparation of these compounds, a pharmaceutical composition comprising the same, and their use in manufacturing a medicament aimed at preventing or treating tumor growth and metastasis. He has 1 patent to his name.
Career Highlights
Xinrui Wu is affiliated with Xiamen University, where he conducts his research and development activities. His work has garnered attention for its potential applications in the medical field, particularly in oncology.
Collaborations
Xinrui Wu has collaborated with notable colleagues, including Xianming Deng and Wei Peng Huang, to advance his research initiatives.
Conclusion
Xinrui Wu's innovative contributions to the field of pharmaceuticals highlight the importance of research in developing new treatments for serious health conditions. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile